Logo image of SAGA.OL

SAGA PURE ASA (SAGA.OL) Stock Fundamental Analysis

OSL:SAGA - Euronext Oslo - NO0010572589 - Common Stock - Currency: NOK

1.335  -0.01 (-0.37%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SAGA. SAGA was compared to 51 industry peers in the Financial Services industry. No worries on liquidiy or solvency for SAGA as it has an excellent financial health rating, but there are worries on the profitability. SAGA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SAGA had negative earnings in the past year.
SAGA had a positive operating cash flow in the past year.
In multiple years SAGA reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: SAGA reported negative operating cash flow in multiple years.
SAGA.OL Yearly Net Income VS EBIT VS OCF VS FCFSAGA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.64%, SAGA is doing worse than 76.47% of the companies in the same industry.
With a Return On Equity value of -0.69%, SAGA is not doing good in the industry: 72.55% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.64%
ROE -0.69%
ROIC N/A
ROA(3y)-5.91%
ROA(5y)5.15%
ROE(3y)-5.95%
ROE(5y)5.23%
ROIC(3y)N/A
ROIC(5y)N/A
SAGA.OL Yearly ROA, ROE, ROICSAGA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

SAGA's Operating Margin has improved in the last couple of years.
SAGA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y28.87%
OM growth 5Y16.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SAGA.OL Yearly Profit, Operating, Gross MarginsSAGA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, SAGA has about the same amount of shares outstanding.
SAGA has more shares outstanding than it did 5 years ago.
SAGA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SAGA.OL Yearly Shares OutstandingSAGA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
SAGA.OL Yearly Total Debt VS Total AssetsSAGA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SAGA has an Altman-Z score of 5.62. This indicates that SAGA is financially healthy and has little risk of bankruptcy at the moment.
SAGA has a better Altman-Z score (5.62) than 84.31% of its industry peers.
The Debt to FCF ratio of SAGA is 0.89, which is an excellent value as it means it would take SAGA, only 0.89 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.89, SAGA belongs to the top of the industry, outperforming 90.20% of the companies in the same industry.
SAGA has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, SAGA belongs to the top of the industry, outperforming 92.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.89
Altman-Z 5.62
ROIC/WACCN/A
WACCN/A
SAGA.OL Yearly LT Debt VS Equity VS FCFSAGA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 131.70 indicates that SAGA has no problem at all paying its short term obligations.
SAGA's Current ratio of 131.70 is amongst the best of the industry. SAGA outperforms 100.00% of its industry peers.
SAGA has a Quick Ratio of 131.70. This indicates that SAGA is financially healthy and has no problem in meeting its short term obligations.
SAGA has a better Quick ratio (131.70) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 131.7
Quick Ratio 131.7
SAGA.OL Yearly Current Assets VS Current LiabilitesSAGA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

0

3. Growth

3.1 Past

SAGA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.81%, which is quite impressive.
Measured over the past years, SAGA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -48.62% on average per year.
SAGA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -163.96%.
EPS 1Y (TTM)82.81%
EPS 3Y-76.41%
EPS 5Y-48.62%
EPS Q2Q%-50.82%
Revenue 1Y (TTM)-163.96%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SAGA.OL Yearly Revenue VS EstimatesSAGA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1

4. Valuation

4.1 Price/Earnings Ratio

SAGA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SAGA.OL Price Earnings VS Forward Price EarningsSAGA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

SAGA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 25.59
EV/EBITDA N/A
SAGA.OL Per share dataSAGA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SAGA!.
Industry RankSector Rank
Dividend Yield N/A

SAGA PURE ASA

OSL:SAGA (7/11/2025, 7:00:00 PM)

1.335

-0.01 (-0.37%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners41.4%
Ins Owner ChangeN/A
Market Cap647.31M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)26.16%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 25.59
P/OCF 25.59
P/B 0.74
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.05
FCFY3.91%
OCF(TTM)0.05
OCFY3.91%
SpS-0.04
BVpS1.81
TBVpS1.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.64%
ROE -0.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM -127.4%
ROA(3y)-5.91%
ROA(5y)5.15%
ROE(3y)-5.95%
ROE(5y)5.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y28.87%
OM growth 5Y16.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover-0.02
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.89
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 131.7
Quick Ratio 131.7
Altman-Z 5.62
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.81%
EPS 3Y-76.41%
EPS 5Y-48.62%
EPS Q2Q%-50.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-163.96%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-3.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-359.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y134.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y134.7%
OCF growth 3YN/A
OCF growth 5YN/A